Abstract
Purpose. To study oral absorption and brain penetration as a function of polar molecular surface area.
Methods. Measured brain penetration data of 45 drug molecules were investigated. The dynamic polar surface areas were calculated and correlated with the brain penetration data. Also the static polar surface areas of 776 orally administered CNS drugs that have reached at least Phase II efficacy studies were calculated. The same was done for a series of 1590 orally administered non-CNS drugs that have reached at least Phase II efficacy studies.
Results. A linear relationship between brain penetration and dynamic polar surface area (Å2) was found (n = 45, R = 0.917, F1,43 = 229). Brain penetration decreases with increasing polar surface area. A clear difference between the distribution of the polar surface area of the 776 CNS and 1590 non-CNS drugs was found. It was deduced that orally active drugs that are transported passively by the transcellular route should not exceed a polar surface area of about 120 Å2. They can be tailored to brain penetration by decreasing the polar surface to <60−70 Å2. This conclusion is supported by the inverse linear relationship between experimental brain penetration data and the dynamic polar surface area of 45 drug molecules.
Conclusions. The polar molecular surface area is a dominating determinant for oral absorption and brain penetration of drugs that are transported by the transcellular route. This property should be considered in the early phase of drug screening.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Rev. 23:3–25 (1997).
K. Palm, P. Stenberg, K. Luthman, and P. Artursson. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm. Res. 14:568–571 (1997).
H. van de Waterbeemd and M. Kansay. Hydrogen-bonding capacity and brain penetration. Chimia 46:299–303 (1992).
R. C. Young, R. C. Mitchell, T. H. Brown, C. R. Ganellin, R. Griffith, M. Jones, K. K. Rana, D. Saunders, I. R. Smith, N. E. Sore, and T. J. Wilks. Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. J. Med. Chem. 31:656–671 (1988).
M. H. Abraham, H. S. Chadha, and R. C. Mitchell. Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. J. Pharm. Sci. 83:1257–1268 (1994).
F. Lombardo, J. F. Blake, and W. J. Curatolo. Computation of brain-blood partitioning of organic solutes via free energy calculations. J. Med. Chem. 39:4750–4755 (1996).
J. H. Lin, I.-W. Chen, and T.-H. Lin. Blood-brain barrier permeability and in vivo activity of partial agonists of benzodiazepine receptor: A study of L-663,581 and its metabolites in rats. J. Pharmacol. Exp. Ther. 271:1197–1202 (1994).
L. E. C. van Beijsterveldt, R. J. F. Geerts, J. E. Leysen, A. A. H. P. Megens, H. M. J. Van den Eynde, W. E. G. Meuldermans, and J. J. P. Heykants. Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat. Psychopharmacol. 114:53–62 (1994).
R. N. Brogden, A. A. Carmine, R. C. Heel, T. M. Speight, and G. S. Avery. Domperidone: A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 24:360–400 (1982).
J. Sadowski and J. Gasteiger. From atoms and bonds to three-dimensional atomic coordinates: atomic model builders. Chem. Rev. 93:2567–2581 (1993).
Molecular Simulations Inc. Quanta 4.0 and CHARMm 23.2.
D. Bayada. Monika. Version 1.0 (1998).
Unistat statistical package for MS Windows. Version 4.5 (1996).
BioByte Corp. ClogP. Version 1.1 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kelder, J., Grootenhuis, P.D.J., Bayada, D.M. et al. Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs. Pharm Res 16, 1514–1519 (1999). https://doi.org/10.1023/A:1015040217741
Issue Date:
DOI: https://doi.org/10.1023/A:1015040217741